ArticleAdvanced science (Weinheim, Baden-Wurttemberg, Germany)2026
BCR::ABL1-Induced Enhancer Reprogramming Uncovers Hypersensitivity of Ph+B-ALL Cells to Enhancer-Targeting Drugs.
Han Leng Ng et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.